nodes	percent_of_prediction	percent_of_DWPC	metapath
Methazolamide—CA9—hematologic cancer	0.246	1	CbGaD
Methazolamide—CA14—Imatinib—hematologic cancer	0.0332	0.061	CbGbCtD
Methazolamide—CA6—Imatinib—hematologic cancer	0.0315	0.0579	CbGbCtD
Methazolamide—CA14—Nilotinib—hematologic cancer	0.0302	0.0554	CbGbCtD
Methazolamide—CA6—Nilotinib—hematologic cancer	0.0286	0.0526	CbGbCtD
Methazolamide—CA7—Imatinib—hematologic cancer	0.0275	0.0505	CbGbCtD
Methazolamide—CA7—Nilotinib—hematologic cancer	0.025	0.0459	CbGbCtD
Methazolamide—CA9—Imatinib—hematologic cancer	0.0236	0.0433	CbGbCtD
Methazolamide—CA12—Imatinib—hematologic cancer	0.0236	0.0433	CbGbCtD
Methazolamide—CA1—Imatinib—hematologic cancer	0.0221	0.0405	CbGbCtD
Methazolamide—CA12—Nilotinib—hematologic cancer	0.0214	0.0394	CbGbCtD
Methazolamide—CA9—Nilotinib—hematologic cancer	0.0214	0.0394	CbGbCtD
Methazolamide—CA1—Nilotinib—hematologic cancer	0.02	0.0368	CbGbCtD
Methazolamide—CA2—Imatinib—hematologic cancer	0.0191	0.035	CbGbCtD
Methazolamide—CA4—Nilotinib—hematologic cancer	0.0188	0.0346	CbGbCtD
Methazolamide—CA2—Nilotinib—hematologic cancer	0.0173	0.0318	CbGbCtD
Methazolamide—CYP2E1—Thalidomide—hematologic cancer	0.00768	0.0141	CbGbCtD
Methazolamide—CYP2C9—Bexarotene—hematologic cancer	0.0075	0.0138	CbGbCtD
Methazolamide—CYP2E1—Dacarbazine—hematologic cancer	0.00661	0.0121	CbGbCtD
Methazolamide—CYP2D6—Lomustine—hematologic cancer	0.00637	0.0117	CbGbCtD
Methazolamide—CYP2C9—Idarubicin—hematologic cancer	0.00621	0.0114	CbGbCtD
Methazolamide—CYP2D6—Idarubicin—hematologic cancer	0.00568	0.0104	CbGbCtD
Methazolamide—CYP2C19—Bortezomib—hematologic cancer	0.00553	0.0102	CbGbCtD
Methazolamide—CYP2E1—Mitoxantrone—hematologic cancer	0.00513	0.00942	CbGbCtD
Methazolamide—CYP2D6—Hydroxyurea—hematologic cancer	0.00483	0.00888	CbGbCtD
Methazolamide—CYP2C19—Thalidomide—hematologic cancer	0.00482	0.00885	CbGbCtD
Methazolamide—CYP2C9—Bortezomib—hematologic cancer	0.0046	0.00845	CbGbCtD
Methazolamide—CYP2C19—Teniposide—hematologic cancer	0.00459	0.00844	CbGbCtD
Methazolamide—CYP3A4—Bexarotene—hematologic cancer	0.00436	0.00801	CbGbCtD
Methazolamide—CYP2C19—Ifosfamide—hematologic cancer	0.00424	0.00779	CbGbCtD
Methazolamide—CYP2D6—Bortezomib—hematologic cancer	0.0042	0.00772	CbGbCtD
Methazolamide—CYP3A4—Lomustine—hematologic cancer	0.00405	0.00745	CbGbCtD
Methazolamide—CYP3A4—Busulfan—hematologic cancer	0.00405	0.00745	CbGbCtD
Methazolamide—CYP2C19—Imatinib—hematologic cancer	0.00405	0.00744	CbGbCtD
Methazolamide—CYP2C9—Thalidomide—hematologic cancer	0.004	0.00736	CbGbCtD
Methazolamide—CYP2C9—Teniposide—hematologic cancer	0.00382	0.00702	CbGbCtD
Methazolamide—CYP3A4—Thiotepa—hematologic cancer	0.00361	0.00664	CbGbCtD
Methazolamide—CYP2C9—Ifosfamide—hematologic cancer	0.00352	0.00648	CbGbCtD
Methazolamide—CYP2C9—Imatinib—hematologic cancer	0.00337	0.00619	CbGbCtD
Methazolamide—CYP2E1—Etoposide—hematologic cancer	0.00323	0.00594	CbGbCtD
Methazolamide—CYP2D6—Imatinib—hematologic cancer	0.00308	0.00566	CbGbCtD
Methazolamide—CYP2C9—Nilotinib—hematologic cancer	0.00306	0.00562	CbGbCtD
Methazolamide—CYP3A4—Methoxsalen—hematologic cancer	0.00281	0.00516	CbGbCtD
Methazolamide—CYP2D6—Nilotinib—hematologic cancer	0.0028	0.00514	CbGbCtD
Methazolamide—CYP2D6—Vinorelbine—hematologic cancer	0.00277	0.0051	CbGbCtD
Methazolamide—CYP3A4—Bortezomib—hematologic cancer	0.00267	0.00491	CbGbCtD
Methazolamide—CYP2C19—Prednisone—hematologic cancer	0.00267	0.0049	CbGbCtD
Methazolamide—CYP2E1—Dexamethasone—hematologic cancer	0.00266	0.00488	CbGbCtD
Methazolamide—CYP3A4—Daunorubicin—hematologic cancer	0.00256	0.0047	CbGbCtD
Methazolamide—SLC22A6—Methotrexate—hematologic cancer	0.00242	0.00446	CbGbCtD
Methazolamide—CYP3A4—Cytarabine—hematologic cancer	0.00225	0.00414	CbGbCtD
Methazolamide—CYP3A4—Teniposide—hematologic cancer	0.00222	0.00408	CbGbCtD
Methazolamide—Acetazolamide—CA9—hematologic cancer	0.00209	1	CrCbGaD
Methazolamide—CYP3A4—Ifosfamide—hematologic cancer	0.00205	0.00377	CbGbCtD
Methazolamide—CYP3A4—Imatinib—hematologic cancer	0.00196	0.0036	CbGbCtD
Methazolamide—CYP3A4—Ruxolitinib—hematologic cancer	0.00184	0.00339	CbGbCtD
Methazolamide—CYP3A4—Nilotinib—hematologic cancer	0.00178	0.00327	CbGbCtD
Methazolamide—CYP3A4—Vinorelbine—hematologic cancer	0.00176	0.00324	CbGbCtD
Methazolamide—CYP2C9—Cisplatin—hematologic cancer	0.00171	0.00315	CbGbCtD
Methazolamide—CYP2D6—Vinblastine—hematologic cancer	0.00171	0.00314	CbGbCtD
Methazolamide—CYP2C19—Dexamethasone—hematologic cancer	0.00167	0.00306	CbGbCtD
Methazolamide—CYP3A4—Triamcinolone—hematologic cancer	0.00161	0.00297	CbGbCtD
Methazolamide—CYP3A4—Dasatinib—hematologic cancer	0.00157	0.00289	CbGbCtD
Methazolamide—CYP3A4—Mitoxantrone—hematologic cancer	0.00155	0.00285	CbGbCtD
Methazolamide—CYP2C9—Dexamethasone—hematologic cancer	0.00138	0.00255	CbGbCtD
Methazolamide—CYP3A4—Betamethasone—hematologic cancer	0.00138	0.00254	CbGbCtD
Methazolamide—CYP3A4—Prednisolone—hematologic cancer	0.00137	0.00251	CbGbCtD
Methazolamide—CYP3A4—Prednisone—hematologic cancer	0.00129	0.00237	CbGbCtD
Methazolamide—CYP2D6—Dexamethasone—hematologic cancer	0.00127	0.00233	CbGbCtD
Methazolamide—CYP3A4—Irinotecan—hematologic cancer	0.00122	0.00225	CbGbCtD
Methazolamide—CYP3A4—Vinblastine—hematologic cancer	0.00109	0.002	CbGbCtD
Methazolamide—CYP3A4—Vincristine—hematologic cancer	0.00107	0.00196	CbGbCtD
Methazolamide—CYP2D6—Doxorubicin—hematologic cancer	0.00105	0.00193	CbGbCtD
Methazolamide—CYP3A4—Etoposide—hematologic cancer	0.000979	0.0018	CbGbCtD
Methazolamide—CYP3A4—Dexamethasone—hematologic cancer	0.000805	0.00148	CbGbCtD
Methazolamide—CA5B—hematopoietic system—hematologic cancer	0.000731	0.0588	CbGeAlD
Methazolamide—CYP3A4—Doxorubicin—hematologic cancer	0.000668	0.00123	CbGbCtD
Methazolamide—CA1—hematopoietic system—hematologic cancer	0.000646	0.0519	CbGeAlD
Methazolamide—CA9—testis—hematologic cancer	0.000604	0.0486	CbGeAlD
Methazolamide—CA5B—gonad—hematologic cancer	0.000556	0.0447	CbGeAlD
Methazolamide—CA5B—blood—hematologic cancer	0.000485	0.039	CbGeAlD
Methazolamide—CA12—lung—hematologic cancer	0.000474	0.0381	CbGeAlD
Methazolamide—CYP2C19—hematopoietic system—hematologic cancer	0.000457	0.0367	CbGeAlD
Methazolamide—CA1—blood—hematologic cancer	0.000428	0.0344	CbGeAlD
Methazolamide—CA5B—lung—hematologic cancer	0.000425	0.0342	CbGeAlD
Methazolamide—CA2—hematopoietic system—hematologic cancer	0.000419	0.0337	CbGeAlD
Methazolamide—CA1—bone marrow—hematologic cancer	0.000414	0.0333	CbGeAlD
Methazolamide—CA5B—testis—hematologic cancer	0.000401	0.0322	CbGeAlD
Methazolamide—CA1—lung—hematologic cancer	0.000375	0.0302	CbGeAlD
Methazolamide—CYP2C9—hematopoietic system—hematologic cancer	0.000354	0.0285	CbGeAlD
Methazolamide—CYP2E1—hematopoietic system—hematologic cancer	0.000336	0.027	CbGeAlD
Methazolamide—CA4—blood—hematologic cancer	0.000335	0.0269	CbGeAlD
Methazolamide—CA4—bone marrow—hematologic cancer	0.000324	0.026	CbGeAlD
Methazolamide—CYP2C19—blood—hematologic cancer	0.000303	0.0243	CbGeAlD
Methazolamide—CA4—lung—hematologic cancer	0.000293	0.0236	CbGeAlD
Methazolamide—CA5B—lymph node—hematologic cancer	0.000291	0.0234	CbGeAlD
Methazolamide—CA2—blood—hematologic cancer	0.000277	0.0223	CbGeAlD
Methazolamide—CA4—testis—hematologic cancer	0.000277	0.0222	CbGeAlD
Methazolamide—CYP3A4—hematopoietic system—hematologic cancer	0.00027	0.0217	CbGeAlD
Methazolamide—CA2—bone marrow—hematologic cancer	0.000268	0.0216	CbGeAlD
Methazolamide—CYP2D6—hematopoietic system—hematologic cancer	0.000266	0.0214	CbGeAlD
Methazolamide—CA1—lymph node—hematologic cancer	0.000257	0.0206	CbGeAlD
Methazolamide—CA2—lung—hematologic cancer	0.000243	0.0195	CbGeAlD
Methazolamide—CYP2C9—blood—hematologic cancer	0.000235	0.0189	CbGeAlD
Methazolamide—CA2—testis—hematologic cancer	0.000229	0.0184	CbGeAlD
Methazolamide—CYP2E1—blood—hematologic cancer	0.000222	0.0179	CbGeAlD
Methazolamide—CA4—lymph node—hematologic cancer	0.000201	0.0161	CbGeAlD
Methazolamide—CYP2E1—lung—hematologic cancer	0.000195	0.0157	CbGeAlD
Methazolamide—CYP2E1—testis—hematologic cancer	0.000184	0.0148	CbGeAlD
Methazolamide—CYP3A4—blood—hematologic cancer	0.000179	0.0144	CbGeAlD
Methazolamide—CYP2D6—blood—hematologic cancer	0.000176	0.0142	CbGeAlD
Methazolamide—CA2—lymph node—hematologic cancer	0.000166	0.0134	CbGeAlD
Methazolamide—CYP2D6—testis—hematologic cancer	0.000146	0.0117	CbGeAlD
Methazolamide—Asthenia—Vincristine—hematologic cancer	5.01e-05	0.000346	CcSEcCtD
Methazolamide—Paraesthesia—Prednisolone—hematologic cancer	5.01e-05	0.000346	CcSEcCtD
Methazolamide—Vomiting—Thiotepa—hematologic cancer	5.01e-05	0.000346	CcSEcCtD
Methazolamide—Diarrhoea—Carmustine—hematologic cancer	5.01e-05	0.000346	CcSEcCtD
Methazolamide—Nausea—Bleomycin—hematologic cancer	4.98e-05	0.000344	CcSEcCtD
Methazolamide—Drowsiness—Epirubicin—hematologic cancer	4.97e-05	0.000344	CcSEcCtD
Methazolamide—Rash—Thiotepa—hematologic cancer	4.97e-05	0.000343	CcSEcCtD
Methazolamide—Dermatitis—Thiotepa—hematologic cancer	4.96e-05	0.000343	CcSEcCtD
Methazolamide—Diarrhoea—Alitretinoin—hematologic cancer	4.96e-05	0.000343	CcSEcCtD
Methazolamide—Agranulocytosis—Methotrexate—hematologic cancer	4.96e-05	0.000343	CcSEcCtD
Methazolamide—Convulsion—Dexamethasone—hematologic cancer	4.94e-05	0.000342	CcSEcCtD
Methazolamide—Convulsion—Betamethasone—hematologic cancer	4.94e-05	0.000342	CcSEcCtD
Methazolamide—Headache—Thiotepa—hematologic cancer	4.94e-05	0.000341	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Epirubicin—hematologic cancer	4.93e-05	0.000341	CcSEcCtD
Methazolamide—Decreased appetite—Etoposide—hematologic cancer	4.92e-05	0.00034	CcSEcCtD
Methazolamide—Diarrhoea—Ifosfamide—hematologic cancer	4.9e-05	0.000339	CcSEcCtD
Methazolamide—Pancytopenia—Doxorubicin—hematologic cancer	4.9e-05	0.000339	CcSEcCtD
Methazolamide—Nausea—Vinorelbine—hematologic cancer	4.9e-05	0.000339	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Etoposide—hematologic cancer	4.89e-05	0.000338	CcSEcCtD
Methazolamide—Body temperature increased—Cisplatin—hematologic cancer	4.88e-05	0.000337	CcSEcCtD
Methazolamide—Asthenia—Mitoxantrone—hematologic cancer	4.88e-05	0.000337	CcSEcCtD
Methazolamide—Asthenia—Irinotecan—hematologic cancer	4.88e-05	0.000337	CcSEcCtD
Methazolamide—Fatigue—Etoposide—hematologic cancer	4.88e-05	0.000337	CcSEcCtD
Methazolamide—Vomiting—Thalidomide—hematologic cancer	4.85e-05	0.000335	CcSEcCtD
Methazolamide—Rash—Thalidomide—hematologic cancer	4.81e-05	0.000332	CcSEcCtD
Methazolamide—Discomfort—Betamethasone—hematologic cancer	4.8e-05	0.000332	CcSEcCtD
Methazolamide—Discomfort—Dexamethasone—hematologic cancer	4.8e-05	0.000332	CcSEcCtD
Methazolamide—Dermatitis—Thalidomide—hematologic cancer	4.8e-05	0.000332	CcSEcCtD
Methazolamide—Diarrhoea—Vincristine—hematologic cancer	4.78e-05	0.00033	CcSEcCtD
Methazolamide—Headache—Thalidomide—hematologic cancer	4.77e-05	0.00033	CcSEcCtD
Methazolamide—Asthenia—Gemcitabine—hematologic cancer	4.76e-05	0.000329	CcSEcCtD
Methazolamide—Haematuria—Epirubicin—hematologic cancer	4.74e-05	0.000328	CcSEcCtD
Methazolamide—Photosensitivity reaction—Doxorubicin—hematologic cancer	4.71e-05	0.000326	CcSEcCtD
Methazolamide—Nausea—Thiotepa—hematologic cancer	4.68e-05	0.000323	CcSEcCtD
Methazolamide—Feeling abnormal—Etoposide—hematologic cancer	4.66e-05	0.000322	CcSEcCtD
Methazolamide—Anaphylactic shock—Betamethasone—hematologic cancer	4.66e-05	0.000322	CcSEcCtD
Methazolamide—Anaphylactic shock—Dexamethasone—hematologic cancer	4.66e-05	0.000322	CcSEcCtD
Methazolamide—Diarrhoea—Mitoxantrone—hematologic cancer	4.66e-05	0.000322	CcSEcCtD
Methazolamide—Diarrhoea—Irinotecan—hematologic cancer	4.66e-05	0.000322	CcSEcCtD
Methazolamide—Vomiting—Carmustine—hematologic cancer	4.65e-05	0.000322	CcSEcCtD
Methazolamide—Agranulocytosis—Epirubicin—hematologic cancer	4.64e-05	0.000321	CcSEcCtD
Methazolamide—Rash—Carmustine—hematologic cancer	4.61e-05	0.000319	CcSEcCtD
Methazolamide—Ill-defined disorder—Prednisone—hematologic cancer	4.61e-05	0.000319	CcSEcCtD
Methazolamide—Dermatitis—Carmustine—hematologic cancer	4.61e-05	0.000319	CcSEcCtD
Methazolamide—Vomiting—Alitretinoin—hematologic cancer	4.61e-05	0.000319	CcSEcCtD
Methazolamide—Paraesthesia—Triamcinolone—hematologic cancer	4.61e-05	0.000319	CcSEcCtD
Methazolamide—Drowsiness—Doxorubicin—hematologic cancer	4.6e-05	0.000318	CcSEcCtD
Methazolamide—Feeling abnormal—Prednisolone—hematologic cancer	4.6e-05	0.000318	CcSEcCtD
Methazolamide—Headache—Carmustine—hematologic cancer	4.59e-05	0.000317	CcSEcCtD
Methazolamide—Rash—Alitretinoin—hematologic cancer	4.57e-05	0.000316	CcSEcCtD
Methazolamide—Dermatitis—Alitretinoin—hematologic cancer	4.57e-05	0.000316	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	4.56e-05	0.000315	CcSEcCtD
Methazolamide—Vomiting—Ifosfamide—hematologic cancer	4.56e-05	0.000315	CcSEcCtD
Methazolamide—Headache—Alitretinoin—hematologic cancer	4.54e-05	0.000314	CcSEcCtD
Methazolamide—Diarrhoea—Gemcitabine—hematologic cancer	4.53e-05	0.000313	CcSEcCtD
Methazolamide—Nausea—Thalidomide—hematologic cancer	4.53e-05	0.000313	CcSEcCtD
Methazolamide—Dyspepsia—Triamcinolone—hematologic cancer	4.52e-05	0.000312	CcSEcCtD
Methazolamide—Rash—Ifosfamide—hematologic cancer	4.52e-05	0.000312	CcSEcCtD
Methazolamide—Dermatitis—Ifosfamide—hematologic cancer	4.51e-05	0.000312	CcSEcCtD
Methazolamide—Erythema multiforme—Methotrexate—hematologic cancer	4.51e-05	0.000312	CcSEcCtD
Methazolamide—Urticaria—Etoposide—hematologic cancer	4.5e-05	0.000311	CcSEcCtD
Methazolamide—Malaise—Prednisone—hematologic cancer	4.48e-05	0.00031	CcSEcCtD
Methazolamide—Body temperature increased—Etoposide—hematologic cancer	4.47e-05	0.000309	CcSEcCtD
Methazolamide—Vertigo—Prednisone—hematologic cancer	4.47e-05	0.000309	CcSEcCtD
Methazolamide—Tinnitus—Methotrexate—hematologic cancer	4.45e-05	0.000307	CcSEcCtD
Methazolamide—Vomiting—Vincristine—hematologic cancer	4.44e-05	0.000307	CcSEcCtD
Methazolamide—Anorexia—Dexamethasone—hematologic cancer	4.44e-05	0.000307	CcSEcCtD
Methazolamide—Anorexia—Betamethasone—hematologic cancer	4.44e-05	0.000307	CcSEcCtD
Methazolamide—Urticaria—Prednisolone—hematologic cancer	4.43e-05	0.000306	CcSEcCtD
Methazolamide—Asthenia—Cisplatin—hematologic cancer	4.43e-05	0.000306	CcSEcCtD
Methazolamide—Fatigue—Triamcinolone—hematologic cancer	4.43e-05	0.000306	CcSEcCtD
Methazolamide—Rash—Vincristine—hematologic cancer	4.41e-05	0.000304	CcSEcCtD
Methazolamide—Dermatitis—Vincristine—hematologic cancer	4.4e-05	0.000304	CcSEcCtD
Methazolamide—Haematuria—Doxorubicin—hematologic cancer	4.39e-05	0.000303	CcSEcCtD
Methazolamide—Headache—Vincristine—hematologic cancer	4.38e-05	0.000302	CcSEcCtD
Methazolamide—Nausea—Carmustine—hematologic cancer	4.35e-05	0.0003	CcSEcCtD
Methazolamide—Vomiting—Mitoxantrone—hematologic cancer	4.33e-05	0.000299	CcSEcCtD
Methazolamide—Vomiting—Irinotecan—hematologic cancer	4.33e-05	0.000299	CcSEcCtD
Methazolamide—Nausea—Alitretinoin—hematologic cancer	4.31e-05	0.000298	CcSEcCtD
Methazolamide—Convulsion—Prednisone—hematologic cancer	4.31e-05	0.000298	CcSEcCtD
Methazolamide—Agranulocytosis—Doxorubicin—hematologic cancer	4.3e-05	0.000297	CcSEcCtD
Methazolamide—Rash—Mitoxantrone—hematologic cancer	4.29e-05	0.000296	CcSEcCtD
Methazolamide—Rash—Irinotecan—hematologic cancer	4.29e-05	0.000296	CcSEcCtD
Methazolamide—Dermatitis—Mitoxantrone—hematologic cancer	4.29e-05	0.000296	CcSEcCtD
Methazolamide—Dermatitis—Irinotecan—hematologic cancer	4.29e-05	0.000296	CcSEcCtD
Methazolamide—Headache—Mitoxantrone—hematologic cancer	4.26e-05	0.000295	CcSEcCtD
Methazolamide—Headache—Irinotecan—hematologic cancer	4.26e-05	0.000295	CcSEcCtD
Methazolamide—Nausea—Ifosfamide—hematologic cancer	4.26e-05	0.000294	CcSEcCtD
Methazolamide—Feeling abnormal—Triamcinolone—hematologic cancer	4.23e-05	0.000292	CcSEcCtD
Methazolamide—Diarrhoea—Cisplatin—hematologic cancer	4.23e-05	0.000292	CcSEcCtD
Methazolamide—Erythema multiforme—Epirubicin—hematologic cancer	4.22e-05	0.000292	CcSEcCtD
Methazolamide—Vomiting—Gemcitabine—hematologic cancer	4.21e-05	0.000291	CcSEcCtD
Methazolamide—Paraesthesia—Dexamethasone—hematologic cancer	4.18e-05	0.000289	CcSEcCtD
Methazolamide—Paraesthesia—Betamethasone—hematologic cancer	4.18e-05	0.000289	CcSEcCtD
Methazolamide—Discomfort—Prednisone—hematologic cancer	4.18e-05	0.000289	CcSEcCtD
Methazolamide—Rash—Gemcitabine—hematologic cancer	4.18e-05	0.000289	CcSEcCtD
Methazolamide—Dermatitis—Gemcitabine—hematologic cancer	4.18e-05	0.000289	CcSEcCtD
Methazolamide—Tinnitus—Epirubicin—hematologic cancer	4.16e-05	0.000288	CcSEcCtD
Methazolamide—Headache—Gemcitabine—hematologic cancer	4.15e-05	0.000287	CcSEcCtD
Methazolamide—Nausea—Vincristine—hematologic cancer	4.15e-05	0.000287	CcSEcCtD
Methazolamide—Dyspepsia—Dexamethasone—hematologic cancer	4.1e-05	0.000283	CcSEcCtD
Methazolamide—Dyspepsia—Betamethasone—hematologic cancer	4.1e-05	0.000283	CcSEcCtD
Methazolamide—Urticaria—Triamcinolone—hematologic cancer	4.08e-05	0.000282	CcSEcCtD
Methazolamide—Dysgeusia—Methotrexate—hematologic cancer	4.07e-05	0.000281	CcSEcCtD
Methazolamide—Asthenia—Etoposide—hematologic cancer	4.06e-05	0.000281	CcSEcCtD
Methazolamide—Body temperature increased—Triamcinolone—hematologic cancer	4.06e-05	0.00028	CcSEcCtD
Methazolamide—Anaphylactic shock—Prednisone—hematologic cancer	4.06e-05	0.00028	CcSEcCtD
Methazolamide—Decreased appetite—Dexamethasone—hematologic cancer	4.05e-05	0.00028	CcSEcCtD
Methazolamide—Decreased appetite—Betamethasone—hematologic cancer	4.05e-05	0.00028	CcSEcCtD
Methazolamide—Nausea—Mitoxantrone—hematologic cancer	4.04e-05	0.000279	CcSEcCtD
Methazolamide—Nausea—Irinotecan—hematologic cancer	4.04e-05	0.000279	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Betamethasone—hematologic cancer	4.02e-05	0.000278	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Dexamethasone—hematologic cancer	4.02e-05	0.000278	CcSEcCtD
Methazolamide—Fatigue—Betamethasone—hematologic cancer	4.02e-05	0.000278	CcSEcCtD
Methazolamide—Fatigue—Dexamethasone—hematologic cancer	4.02e-05	0.000278	CcSEcCtD
Methazolamide—Nausea—Gemcitabine—hematologic cancer	3.94e-05	0.000272	CcSEcCtD
Methazolamide—Vomiting—Cisplatin—hematologic cancer	3.93e-05	0.000271	CcSEcCtD
Methazolamide—Erythema multiforme—Doxorubicin—hematologic cancer	3.91e-05	0.00027	CcSEcCtD
Methazolamide—Rash—Cisplatin—hematologic cancer	3.9e-05	0.000269	CcSEcCtD
Methazolamide—Dermatitis—Cisplatin—hematologic cancer	3.89e-05	0.000269	CcSEcCtD
Methazolamide—Diarrhoea—Etoposide—hematologic cancer	3.87e-05	0.000268	CcSEcCtD
Methazolamide—Anorexia—Prednisone—hematologic cancer	3.87e-05	0.000267	CcSEcCtD
Methazolamide—Ill-defined disorder—Methotrexate—hematologic cancer	3.85e-05	0.000266	CcSEcCtD
Methazolamide—Tinnitus—Doxorubicin—hematologic cancer	3.85e-05	0.000266	CcSEcCtD
Methazolamide—Feeling abnormal—Betamethasone—hematologic cancer	3.84e-05	0.000265	CcSEcCtD
Methazolamide—Feeling abnormal—Dexamethasone—hematologic cancer	3.84e-05	0.000265	CcSEcCtD
Methazolamide—Dysgeusia—Epirubicin—hematologic cancer	3.81e-05	0.000263	CcSEcCtD
Methazolamide—Malaise—Methotrexate—hematologic cancer	3.75e-05	0.000259	CcSEcCtD
Methazolamide—Vertigo—Methotrexate—hematologic cancer	3.73e-05	0.000258	CcSEcCtD
Methazolamide—Leukopenia—Methotrexate—hematologic cancer	3.72e-05	0.000257	CcSEcCtD
Methazolamide—Urticaria—Dexamethasone—hematologic cancer	3.7e-05	0.000256	CcSEcCtD
Methazolamide—Urticaria—Betamethasone—hematologic cancer	3.7e-05	0.000256	CcSEcCtD
Methazolamide—Asthenia—Triamcinolone—hematologic cancer	3.68e-05	0.000255	CcSEcCtD
Methazolamide—Body temperature increased—Dexamethasone—hematologic cancer	3.68e-05	0.000254	CcSEcCtD
Methazolamide—Body temperature increased—Betamethasone—hematologic cancer	3.68e-05	0.000254	CcSEcCtD
Methazolamide—Nausea—Cisplatin—hematologic cancer	3.67e-05	0.000254	CcSEcCtD
Methazolamide—Paraesthesia—Prednisone—hematologic cancer	3.64e-05	0.000252	CcSEcCtD
Methazolamide—Ill-defined disorder—Epirubicin—hematologic cancer	3.61e-05	0.000249	CcSEcCtD
Methazolamide—Convulsion—Methotrexate—hematologic cancer	3.6e-05	0.000249	CcSEcCtD
Methazolamide—Vomiting—Etoposide—hematologic cancer	3.6e-05	0.000249	CcSEcCtD
Methazolamide—Dyspepsia—Prednisone—hematologic cancer	3.57e-05	0.000247	CcSEcCtD
Methazolamide—Rash—Etoposide—hematologic cancer	3.57e-05	0.000247	CcSEcCtD
Methazolamide—Dermatitis—Etoposide—hematologic cancer	3.57e-05	0.000246	CcSEcCtD
Methazolamide—Headache—Etoposide—hematologic cancer	3.55e-05	0.000245	CcSEcCtD
Methazolamide—Decreased appetite—Prednisone—hematologic cancer	3.53e-05	0.000244	CcSEcCtD
Methazolamide—Dysgeusia—Doxorubicin—hematologic cancer	3.52e-05	0.000243	CcSEcCtD
Methazolamide—Rash—Prednisolone—hematologic cancer	3.52e-05	0.000243	CcSEcCtD
Methazolamide—Dermatitis—Prednisolone—hematologic cancer	3.52e-05	0.000243	CcSEcCtD
Methazolamide—Malaise—Epirubicin—hematologic cancer	3.51e-05	0.000242	CcSEcCtD
Methazolamide—Fatigue—Prednisone—hematologic cancer	3.5e-05	0.000242	CcSEcCtD
Methazolamide—Headache—Prednisolone—hematologic cancer	3.5e-05	0.000242	CcSEcCtD
Methazolamide—Discomfort—Methotrexate—hematologic cancer	3.49e-05	0.000241	CcSEcCtD
Methazolamide—Vertigo—Epirubicin—hematologic cancer	3.49e-05	0.000241	CcSEcCtD
Methazolamide—Leukopenia—Epirubicin—hematologic cancer	3.48e-05	0.00024	CcSEcCtD
Methazolamide—Confusional state—Methotrexate—hematologic cancer	3.42e-05	0.000236	CcSEcCtD
Methazolamide—Anaphylactic shock—Methotrexate—hematologic cancer	3.39e-05	0.000234	CcSEcCtD
Methazolamide—Convulsion—Epirubicin—hematologic cancer	3.37e-05	0.000233	CcSEcCtD
Methazolamide—Nausea—Etoposide—hematologic cancer	3.36e-05	0.000232	CcSEcCtD
Methazolamide—Feeling abnormal—Prednisone—hematologic cancer	3.34e-05	0.000231	CcSEcCtD
Methazolamide—Asthenia—Dexamethasone—hematologic cancer	3.34e-05	0.000231	CcSEcCtD
Methazolamide—Asthenia—Betamethasone—hematologic cancer	3.34e-05	0.000231	CcSEcCtD
Methazolamide—Ill-defined disorder—Doxorubicin—hematologic cancer	3.34e-05	0.000231	CcSEcCtD
Methazolamide—Nausea—Prednisolone—hematologic cancer	3.32e-05	0.000229	CcSEcCtD
Methazolamide—Discomfort—Epirubicin—hematologic cancer	3.27e-05	0.000226	CcSEcCtD
Methazolamide—Vomiting—Triamcinolone—hematologic cancer	3.26e-05	0.000226	CcSEcCtD
Methazolamide—Malaise—Doxorubicin—hematologic cancer	3.24e-05	0.000224	CcSEcCtD
Methazolamide—Rash—Triamcinolone—hematologic cancer	3.24e-05	0.000224	CcSEcCtD
Methazolamide—Dermatitis—Triamcinolone—hematologic cancer	3.23e-05	0.000223	CcSEcCtD
Methazolamide—Vertigo—Doxorubicin—hematologic cancer	3.23e-05	0.000223	CcSEcCtD
Methazolamide—Anorexia—Methotrexate—hematologic cancer	3.23e-05	0.000223	CcSEcCtD
Methazolamide—Urticaria—Prednisone—hematologic cancer	3.22e-05	0.000223	CcSEcCtD
Methazolamide—Leukopenia—Doxorubicin—hematologic cancer	3.22e-05	0.000222	CcSEcCtD
Methazolamide—Headache—Triamcinolone—hematologic cancer	3.22e-05	0.000222	CcSEcCtD
Methazolamide—Body temperature increased—Prednisone—hematologic cancer	3.21e-05	0.000222	CcSEcCtD
Methazolamide—Confusional state—Epirubicin—hematologic cancer	3.2e-05	0.000221	CcSEcCtD
Methazolamide—Diarrhoea—Betamethasone—hematologic cancer	3.19e-05	0.00022	CcSEcCtD
Methazolamide—Diarrhoea—Dexamethasone—hematologic cancer	3.19e-05	0.00022	CcSEcCtD
Methazolamide—Anaphylactic shock—Epirubicin—hematologic cancer	3.17e-05	0.000219	CcSEcCtD
Methazolamide—Convulsion—Doxorubicin—hematologic cancer	3.12e-05	0.000215	CcSEcCtD
Methazolamide—Nausea—Triamcinolone—hematologic cancer	3.05e-05	0.000211	CcSEcCtD
Methazolamide—Paraesthesia—Methotrexate—hematologic cancer	3.04e-05	0.00021	CcSEcCtD
Methazolamide—Discomfort—Doxorubicin—hematologic cancer	3.03e-05	0.000209	CcSEcCtD
Methazolamide—Anorexia—Epirubicin—hematologic cancer	3.02e-05	0.000209	CcSEcCtD
Methazolamide—Somnolence—Methotrexate—hematologic cancer	3.01e-05	0.000208	CcSEcCtD
Methazolamide—Dyspepsia—Methotrexate—hematologic cancer	2.98e-05	0.000206	CcSEcCtD
Methazolamide—Vomiting—Dexamethasone—hematologic cancer	2.96e-05	0.000205	CcSEcCtD
Methazolamide—Vomiting—Betamethasone—hematologic cancer	2.96e-05	0.000205	CcSEcCtD
Methazolamide—Confusional state—Doxorubicin—hematologic cancer	2.96e-05	0.000205	CcSEcCtD
Methazolamide—Decreased appetite—Methotrexate—hematologic cancer	2.95e-05	0.000204	CcSEcCtD
Methazolamide—Rash—Betamethasone—hematologic cancer	2.94e-05	0.000203	CcSEcCtD
Methazolamide—Rash—Dexamethasone—hematologic cancer	2.94e-05	0.000203	CcSEcCtD
Methazolamide—Anaphylactic shock—Doxorubicin—hematologic cancer	2.94e-05	0.000203	CcSEcCtD
Methazolamide—Dermatitis—Dexamethasone—hematologic cancer	2.93e-05	0.000203	CcSEcCtD
Methazolamide—Dermatitis—Betamethasone—hematologic cancer	2.93e-05	0.000203	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.93e-05	0.000202	CcSEcCtD
Methazolamide—Fatigue—Methotrexate—hematologic cancer	2.92e-05	0.000202	CcSEcCtD
Methazolamide—Headache—Betamethasone—hematologic cancer	2.92e-05	0.000202	CcSEcCtD
Methazolamide—Headache—Dexamethasone—hematologic cancer	2.92e-05	0.000202	CcSEcCtD
Methazolamide—Asthenia—Prednisone—hematologic cancer	2.91e-05	0.000201	CcSEcCtD
Methazolamide—Paraesthesia—Epirubicin—hematologic cancer	2.85e-05	0.000197	CcSEcCtD
Methazolamide—Somnolence—Epirubicin—hematologic cancer	2.82e-05	0.000195	CcSEcCtD
Methazolamide—Anorexia—Doxorubicin—hematologic cancer	2.8e-05	0.000193	CcSEcCtD
Methazolamide—Feeling abnormal—Methotrexate—hematologic cancer	2.79e-05	0.000193	CcSEcCtD
Methazolamide—Dyspepsia—Epirubicin—hematologic cancer	2.79e-05	0.000193	CcSEcCtD
Methazolamide—Diarrhoea—Prednisone—hematologic cancer	2.78e-05	0.000192	CcSEcCtD
Methazolamide—Nausea—Dexamethasone—hematologic cancer	2.77e-05	0.000191	CcSEcCtD
Methazolamide—Nausea—Betamethasone—hematologic cancer	2.77e-05	0.000191	CcSEcCtD
Methazolamide—Decreased appetite—Epirubicin—hematologic cancer	2.76e-05	0.000191	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.74e-05	0.000189	CcSEcCtD
Methazolamide—Fatigue—Epirubicin—hematologic cancer	2.74e-05	0.000189	CcSEcCtD
Methazolamide—Urticaria—Methotrexate—hematologic cancer	2.69e-05	0.000186	CcSEcCtD
Methazolamide—Body temperature increased—Methotrexate—hematologic cancer	2.68e-05	0.000185	CcSEcCtD
Methazolamide—Paraesthesia—Doxorubicin—hematologic cancer	2.64e-05	0.000182	CcSEcCtD
Methazolamide—Feeling abnormal—Epirubicin—hematologic cancer	2.61e-05	0.000181	CcSEcCtD
Methazolamide—Somnolence—Doxorubicin—hematologic cancer	2.61e-05	0.00018	CcSEcCtD
Methazolamide—Dyspepsia—Doxorubicin—hematologic cancer	2.58e-05	0.000179	CcSEcCtD
Methazolamide—Vomiting—Prednisone—hematologic cancer	2.58e-05	0.000178	CcSEcCtD
Methazolamide—Rash—Prednisone—hematologic cancer	2.56e-05	0.000177	CcSEcCtD
Methazolamide—Dermatitis—Prednisone—hematologic cancer	2.56e-05	0.000177	CcSEcCtD
Methazolamide—Decreased appetite—Doxorubicin—hematologic cancer	2.55e-05	0.000176	CcSEcCtD
Methazolamide—Headache—Prednisone—hematologic cancer	2.54e-05	0.000176	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.53e-05	0.000175	CcSEcCtD
Methazolamide—Fatigue—Doxorubicin—hematologic cancer	2.53e-05	0.000175	CcSEcCtD
Methazolamide—Urticaria—Epirubicin—hematologic cancer	2.52e-05	0.000174	CcSEcCtD
Methazolamide—Body temperature increased—Epirubicin—hematologic cancer	2.51e-05	0.000173	CcSEcCtD
Methazolamide—Asthenia—Methotrexate—hematologic cancer	2.43e-05	0.000168	CcSEcCtD
Methazolamide—Feeling abnormal—Doxorubicin—hematologic cancer	2.42e-05	0.000167	CcSEcCtD
Methazolamide—Nausea—Prednisone—hematologic cancer	2.41e-05	0.000167	CcSEcCtD
Methazolamide—Urticaria—Doxorubicin—hematologic cancer	2.33e-05	0.000161	CcSEcCtD
Methazolamide—Body temperature increased—Doxorubicin—hematologic cancer	2.32e-05	0.00016	CcSEcCtD
Methazolamide—Diarrhoea—Methotrexate—hematologic cancer	2.32e-05	0.00016	CcSEcCtD
Methazolamide—Asthenia—Epirubicin—hematologic cancer	2.28e-05	0.000157	CcSEcCtD
Methazolamide—Diarrhoea—Epirubicin—hematologic cancer	2.17e-05	0.00015	CcSEcCtD
Methazolamide—Vomiting—Methotrexate—hematologic cancer	2.16e-05	0.000149	CcSEcCtD
Methazolamide—Rash—Methotrexate—hematologic cancer	2.14e-05	0.000148	CcSEcCtD
Methazolamide—Dermatitis—Methotrexate—hematologic cancer	2.14e-05	0.000148	CcSEcCtD
Methazolamide—Headache—Methotrexate—hematologic cancer	2.12e-05	0.000147	CcSEcCtD
Methazolamide—Asthenia—Doxorubicin—hematologic cancer	2.11e-05	0.000146	CcSEcCtD
Methazolamide—Vomiting—Epirubicin—hematologic cancer	2.02e-05	0.000139	CcSEcCtD
Methazolamide—Nausea—Methotrexate—hematologic cancer	2.01e-05	0.000139	CcSEcCtD
Methazolamide—Diarrhoea—Doxorubicin—hematologic cancer	2.01e-05	0.000139	CcSEcCtD
Methazolamide—Rash—Epirubicin—hematologic cancer	2e-05	0.000138	CcSEcCtD
Methazolamide—Dermatitis—Epirubicin—hematologic cancer	2e-05	0.000138	CcSEcCtD
Methazolamide—Headache—Epirubicin—hematologic cancer	1.99e-05	0.000137	CcSEcCtD
Methazolamide—Nausea—Epirubicin—hematologic cancer	1.88e-05	0.00013	CcSEcCtD
Methazolamide—Vomiting—Doxorubicin—hematologic cancer	1.87e-05	0.000129	CcSEcCtD
Methazolamide—Rash—Doxorubicin—hematologic cancer	1.85e-05	0.000128	CcSEcCtD
Methazolamide—Dermatitis—Doxorubicin—hematologic cancer	1.85e-05	0.000128	CcSEcCtD
Methazolamide—Headache—Doxorubicin—hematologic cancer	1.84e-05	0.000127	CcSEcCtD
Methazolamide—Nausea—Doxorubicin—hematologic cancer	1.74e-05	0.00012	CcSEcCtD
Methazolamide—CYP3A4—Metabolism—HDC—hematologic cancer	5.02e-06	9.83e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PIK3R1—hematologic cancer	4.98e-06	9.74e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—NCOA3—hematologic cancer	4.97e-06	9.73e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ADCY7—hematologic cancer	4.97e-06	9.73e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—IDH2—hematologic cancer	4.95e-06	9.69e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—HMMR—hematologic cancer	4.95e-06	9.69e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—NUP214—hematologic cancer	4.94e-06	9.66e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CA9—hematologic cancer	4.92e-06	9.63e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ACP5—hematologic cancer	4.92e-06	9.63e-05	CbGpPWpGaD
Methazolamide—CA4—Metabolism—PTEN—hematologic cancer	4.91e-06	9.61e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—IDH2—hematologic cancer	4.91e-06	9.6e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—HMMR—hematologic cancer	4.91e-06	9.6e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—NCOR2—hematologic cancer	4.86e-06	9.51e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—MTR—hematologic cancer	4.84e-06	9.46e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ABCG2—hematologic cancer	4.84e-06	9.46e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ENO2—hematologic cancer	4.74e-06	9.28e-05	CbGpPWpGaD
Methazolamide—CA2—Metabolism—PTEN—hematologic cancer	4.71e-06	9.22e-05	CbGpPWpGaD
Methazolamide—CA7—Metabolism—PIK3CA—hematologic cancer	4.69e-06	9.18e-05	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—PIK3CA—hematologic cancer	4.69e-06	9.18e-05	CbGpPWpGaD
Methazolamide—CA4—Metabolism—EP300—hematologic cancer	4.69e-06	9.17e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ARNTL—hematologic cancer	4.65e-06	9.11e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—IDH1—hematologic cancer	4.63e-06	9.06e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	4.63e-06	9.05e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ARNTL—hematologic cancer	4.61e-06	9.03e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GSTT1—hematologic cancer	4.6e-06	9e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PIK3CB—hematologic cancer	4.59e-06	8.99e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CDA—hematologic cancer	4.59e-06	8.99e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ABCC3—hematologic cancer	4.58e-06	8.95e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GSTO1—hematologic cancer	4.58e-06	8.95e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—TXN—hematologic cancer	4.58e-06	8.95e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CA9—hematologic cancer	4.53e-06	8.86e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ACP5—hematologic cancer	4.53e-06	8.86e-05	CbGpPWpGaD
Methazolamide—CA1—Metabolism—PTEN—hematologic cancer	4.52e-06	8.84e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—SDC1—hematologic cancer	4.5e-06	8.8e-05	CbGpPWpGaD
Methazolamide—CA2—Metabolism—EP300—hematologic cancer	4.49e-06	8.79e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CA9—hematologic cancer	4.49e-06	8.78e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ACP5—hematologic cancer	4.49e-06	8.78e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—SPHK1—hematologic cancer	4.48e-06	8.76e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—NCOR2—hematologic cancer	4.47e-06	8.74e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—NCOR2—hematologic cancer	4.43e-06	8.67e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PC—hematologic cancer	4.42e-06	8.65e-05	CbGpPWpGaD
Methazolamide—CA12—Metabolism—PIK3CA—hematologic cancer	4.35e-06	8.5e-05	CbGpPWpGaD
Methazolamide—CA1—Metabolism—EP300—hematologic cancer	4.31e-06	8.43e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—UGT1A1—hematologic cancer	4.3e-06	8.42e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SLC35B2—hematologic cancer	4.27e-06	8.36e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GBA—hematologic cancer	4.27e-06	8.36e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—IDH1—hematologic cancer	4.26e-06	8.33e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—IDH1—hematologic cancer	4.22e-06	8.26e-05	CbGpPWpGaD
Methazolamide—CA14—Metabolism—AKT1—hematologic cancer	4.21e-06	8.24e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—TXN—hematologic cancer	4.21e-06	8.24e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ABCC3—hematologic cancer	4.21e-06	8.24e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GSTO1—hematologic cancer	4.21e-06	8.24e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—SLC22A1—hematologic cancer	4.19e-06	8.19e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CRABP1—hematologic cancer	4.19e-06	8.19e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—TXN—hematologic cancer	4.17e-06	8.16e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ABCC3—hematologic cancer	4.17e-06	8.16e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GSTO1—hematologic cancer	4.17e-06	8.16e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—SPHK1—hematologic cancer	4.12e-06	8.06e-05	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—AKT1—hematologic cancer	4.1e-06	8.03e-05	CbGpPWpGaD
Methazolamide—CA6—Metabolism—AKT1—hematologic cancer	4.1e-06	8.03e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—SPHK1—hematologic cancer	4.08e-06	7.99e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ALOX5—hematologic cancer	4.08e-06	7.98e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PTEN—hematologic cancer	3.97e-06	7.77e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—UGT1A1—hematologic cancer	3.96e-06	7.74e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—NUP98—hematologic cancer	3.95e-06	7.73e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—UGT1A1—hematologic cancer	3.92e-06	7.68e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—MTAP—hematologic cancer	3.91e-06	7.64e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—SLC22A1—hematologic cancer	3.85e-06	7.53e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CRABP1—hematologic cancer	3.85e-06	7.53e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ADCY7—hematologic cancer	3.84e-06	7.5e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—NCOA3—hematologic cancer	3.84e-06	7.5e-05	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—AKT1—hematologic cancer	3.83e-06	7.5e-05	CbGpPWpGaD
Methazolamide—CA7—Metabolism—AKT1—hematologic cancer	3.83e-06	7.5e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—NQO1—hematologic cancer	3.82e-06	7.48e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CD44—hematologic cancer	3.82e-06	7.48e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—SLC22A1—hematologic cancer	3.82e-06	7.47e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CRABP1—hematologic cancer	3.82e-06	7.47e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—NUP214—hematologic cancer	3.81e-06	7.45e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—EP300—hematologic cancer	3.79e-06	7.41e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.77e-06	7.37e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ALOX5—hematologic cancer	3.75e-06	7.34e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—MTR—hematologic cancer	3.73e-06	7.3e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ABCG2—hematologic cancer	3.73e-06	7.3e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ALOX5—hematologic cancer	3.72e-06	7.28e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ENO2—hematologic cancer	3.66e-06	7.16e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—NUP98—hematologic cancer	3.63e-06	7.11e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CYCS—hematologic cancer	3.62e-06	7.08e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—NUP98—hematologic cancer	3.6e-06	7.05e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—HSP90AA1—hematologic cancer	3.59e-06	7.03e-05	CbGpPWpGaD
Methazolamide—CA12—Metabolism—AKT1—hematologic cancer	3.55e-06	6.95e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GSTT1—hematologic cancer	3.55e-06	6.94e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—NCOA3—hematologic cancer	3.53e-06	6.9e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ADCY7—hematologic cancer	3.53e-06	6.9e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—NUP214—hematologic cancer	3.5e-06	6.85e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ADCY7—hematologic cancer	3.5e-06	6.84e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—NCOA3—hematologic cancer	3.5e-06	6.84e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.49e-06	6.84e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—FHL2—hematologic cancer	3.48e-06	6.81e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—NUP214—hematologic cancer	3.47e-06	6.79e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—SDC1—hematologic cancer	3.47e-06	6.79e-05	CbGpPWpGaD
Methazolamide—CA4—Metabolism—PIK3CA—hematologic cancer	3.47e-06	6.78e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.44e-06	6.72e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ABCG2—hematologic cancer	3.43e-06	6.71e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—MTR—hematologic cancer	3.43e-06	6.71e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—AGRN—hematologic cancer	3.41e-06	6.68e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ABCG2—hematologic cancer	3.4e-06	6.66e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—MTR—hematologic cancer	3.4e-06	6.66e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ENO2—hematologic cancer	3.37e-06	6.58e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ENO2—hematologic cancer	3.34e-06	6.53e-05	CbGpPWpGaD
Methazolamide—CA2—Metabolism—PIK3CA—hematologic cancer	3.32e-06	6.5e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.31e-06	6.48e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.27e-06	6.4e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GSTT1—hematologic cancer	3.26e-06	6.39e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—IDH2—hematologic cancer	3.24e-06	6.33e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HMMR—hematologic cancer	3.24e-06	6.33e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GSTT1—hematologic cancer	3.24e-06	6.33e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—SDC1—hematologic cancer	3.19e-06	6.24e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GSTP1—hematologic cancer	3.19e-06	6.24e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.19e-06	6.23e-05	CbGpPWpGaD
Methazolamide—CA1—Metabolism—PIK3CA—hematologic cancer	3.19e-06	6.23e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—SDC1—hematologic cancer	3.16e-06	6.19e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.13e-06	6.12e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.04e-06	5.95e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.02e-06	5.91e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ABCB1—hematologic cancer	3.02e-06	5.9e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.98e-06	5.83e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ACP5—hematologic cancer	2.96e-06	5.79e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CA9—hematologic cancer	2.96e-06	5.79e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—NQO1—hematologic cancer	2.95e-06	5.77e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CD44—hematologic cancer	2.95e-06	5.77e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—NCOR1—hematologic cancer	2.93e-06	5.73e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GSTM1—hematologic cancer	2.93e-06	5.73e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NCOR2—hematologic cancer	2.92e-06	5.72e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.89e-06	5.65e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.85e-06	5.58e-05	CbGpPWpGaD
Methazolamide—CA4—Metabolism—AKT1—hematologic cancer	2.83e-06	5.54e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PIK3CA—hematologic cancer	2.8e-06	5.48e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYCS—hematologic cancer	2.79e-06	5.46e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—IDH1—hematologic cancer	2.78e-06	5.45e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	2.77e-06	5.43e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GSTO1—hematologic cancer	2.75e-06	5.38e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ABCC3—hematologic cancer	2.75e-06	5.38e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—TXN—hematologic cancer	2.75e-06	5.38e-05	CbGpPWpGaD
Methazolamide—CA2—Metabolism—AKT1—hematologic cancer	2.71e-06	5.31e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—NQO1—hematologic cancer	2.71e-06	5.31e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CD44—hematologic cancer	2.71e-06	5.31e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SPHK1—hematologic cancer	2.69e-06	5.27e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CD44—hematologic cancer	2.69e-06	5.26e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—NQO1—hematologic cancer	2.69e-06	5.26e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.63e-06	5.15e-05	CbGpPWpGaD
Methazolamide—CA1—Metabolism—AKT1—hematologic cancer	2.6e-06	5.09e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—MTHFR—hematologic cancer	2.59e-06	5.07e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—UGT1A1—hematologic cancer	2.59e-06	5.06e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYCS—hematologic cancer	2.57e-06	5.02e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	2.55e-06	4.99e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYCS—hematologic cancer	2.54e-06	4.98e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	2.53e-06	4.95e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SLC22A1—hematologic cancer	2.52e-06	4.92e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CRABP1—hematologic cancer	2.52e-06	4.92e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.5e-06	4.88e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GSTP1—hematologic cancer	2.46e-06	4.81e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.45e-06	4.8e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.38e-06	4.66e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NUP98—hematologic cancer	2.38e-06	4.65e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ABCB1—hematologic cancer	2.33e-06	4.56e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.31e-06	4.51e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.31e-06	4.51e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NUP214—hematologic cancer	2.29e-06	4.48e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—AKT1—hematologic cancer	2.29e-06	4.48e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.28e-06	4.45e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GSTP1—hematologic cancer	2.26e-06	4.43e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GSTM1—hematologic cancer	2.26e-06	4.42e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—NCOR1—hematologic cancer	2.26e-06	4.42e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.24e-06	4.39e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—MTR—hematologic cancer	2.24e-06	4.39e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GSTP1—hematologic cancer	2.24e-06	4.39e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ENO2—hematologic cancer	2.2e-06	4.3e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PIK3CG—hematologic cancer	2.18e-06	4.26e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.17e-06	4.25e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ABCB1—hematologic cancer	2.14e-06	4.19e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.13e-06	4.18e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.12e-06	4.15e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SDC1—hematologic cancer	2.09e-06	4.08e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.08e-06	4.07e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.08e-06	4.07e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.06e-06	4.03e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.06e-06	4.03e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CREBBP—hematologic cancer	2.02e-06	3.95e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—MTHFR—hematologic cancer	2e-06	3.91e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PIK3CD—hematologic cancer	1.91e-06	3.74e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ALB—hematologic cancer	1.89e-06	3.69e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—MTHFR—hematologic cancer	1.84e-06	3.59e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—MTHFR—hematologic cancer	1.82e-06	3.56e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PIK3R1—hematologic cancer	1.81e-06	3.53e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NQO1—hematologic cancer	1.77e-06	3.47e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CD44—hematologic cancer	1.77e-06	3.47e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.76e-06	3.44e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PIK3CG—hematologic cancer	1.68e-06	3.28e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYCS—hematologic cancer	1.68e-06	3.28e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.67e-06	3.26e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PIK3CB—hematologic cancer	1.67e-06	3.26e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.61e-06	3.14e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CREBBP—hematologic cancer	1.56e-06	3.04e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.54e-06	3.02e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.53e-06	2.99e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.48e-06	2.89e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.48e-06	2.89e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ALB—hematologic cancer	1.46e-06	2.85e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PTEN—hematologic cancer	1.44e-06	2.82e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.43e-06	2.8e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.42e-06	2.78e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.4e-06	2.74e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.39e-06	2.73e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—EP300—hematologic cancer	1.37e-06	2.69e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.36e-06	2.66e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.36e-06	2.66e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.36e-06	2.66e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.35e-06	2.63e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ALB—hematologic cancer	1.34e-06	2.62e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ALB—hematologic cancer	1.33e-06	2.6e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.29e-06	2.52e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.28e-06	2.51e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.27e-06	2.49e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.2e-06	2.35e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.18e-06	2.31e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.17e-06	2.29e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PTEN—hematologic cancer	1.11e-06	2.17e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—EP300—hematologic cancer	1.06e-06	2.07e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PTEN—hematologic cancer	1.02e-06	2e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PIK3CA—hematologic cancer	1.02e-06	1.99e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PTEN—hematologic cancer	1.01e-06	1.98e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.01e-06	1.97e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—EP300—hematologic cancer	9.75e-07	1.91e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—EP300—hematologic cancer	9.66e-07	1.89e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CREBBP—hematologic cancer	9.36e-07	1.83e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PIK3CD—hematologic cancer	8.87e-07	1.74e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ALB—hematologic cancer	8.76e-07	1.71e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PIK3R1—hematologic cancer	8.38e-07	1.64e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—AKT1—hematologic cancer	8.3e-07	1.62e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PIK3CA—hematologic cancer	7.84e-07	1.53e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PIK3CB—hematologic cancer	7.73e-07	1.51e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PIK3CA—hematologic cancer	7.21e-07	1.41e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PIK3CA—hematologic cancer	7.15e-07	1.4e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PTEN—hematologic cancer	6.68e-07	1.31e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—AKT1—hematologic cancer	6.4e-07	1.25e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—EP300—hematologic cancer	6.37e-07	1.25e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—AKT1—hematologic cancer	5.89e-07	1.15e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—AKT1—hematologic cancer	5.84e-07	1.14e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PIK3CA—hematologic cancer	4.71e-07	9.22e-06	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—AKT1—hematologic cancer	3.85e-07	7.54e-06	CbGpPWpGaD
